The biotech and healthcare sector has been hot in the past few years. Almost every week new biotech IPOs are coming to the market and investor appetite for these stocks seems no sign of waning. According to a report by BNY Mellon, more than 150 foreign Biotech and Healthcare stocks are listed or traded on the US markets.
In addition, many companies are also raising capital in the US by listing their DRs. About 44 firms raised capital from 2013 to 2017. The table below shows the top 20 in that group:
Click to enlarge
Source: BNY Mellon
Related:
